BRAF and neoplasm: Recent findings indicate that CXCL8 production by cancer cells in vitro is regulated at multiple levels and is strongly influenced by the tumor’s genetic profile, particularly mutations in genes such as BRAF and Phosphatase and Tensin Homolog (PTEN) [67].